Contributors


Leona Downey

Latest:

How Yoga Helped Me in My Post Breast Cancer Treatment Journey

A former oncologist discusses how yoga became a vital part of her recovery after a surprise breast cancer diagnosis.



Kathryn E. Vinson, MS, CCRC

Latest:

Causes of Thyroid Cancer

New research sheds lights on the causes of thyroid cancer, overdiagnosis of PTC


Dr. Kevin Kalinsky

Latest:

Dr. Kevin Kalinsky Covers Targeted Therapy in HER2– Breast Cancer

Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, HER2-negative breast cancer.


June Burke

Latest:

When an Unexpected Cancer Association Leads to a Lifelong Connection

A lung cancer survivor explains how a serendipitous friendship with her stepson’s girlfriend’s aunt changed her life.


Kyle Doherty

Latest:

Key Immune Cells Linked to Better Kidney Cancer Outcomes

PD-1 treatment may help by shifting certain immune cells to fight diseases like kidney cancer; higher CD163-positive TAMs are linked to better outcomes.


Christina Flandera

Latest:

Living With Breast Cancer

After receiving a diagnosis of breast cancer, I received so much support from my family, friends and others.


Jessica Baladad

Latest:

I Stood Up for My Breast Health Amid Ignorant Cancer Comments

After receiving a breast cancer diagnosis, I was faced with many people offering “advice” or commentary about the disease.


Emily Campbell, M.S.

Latest:

One-of-a-Kind Cancer Care Across 1,000 Miles

While one woman always assumed her aunt Judy provided excellent cancer care, she learned it firsthand upon her own diagnosis.


Dr. Nicholas James

Latest:

Understanding the Risk of Overtreatment in Prostate Cancer

Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.


Geri Maroney

Latest:

The Emotional Trauma of Breast Cancer: ‘Can Anybody Hear Me?’

A breast cancer survivor explains that many people deal with long-term emotional trauma as a result of their cancer experience and argues that more should be done to address it.


Lisa O’Neill Hill

Latest:

A Champion for Expanding Access to Lung Cancer Breakthroughs

A colleague describes Dr. Edward S. Kim’s devotion to improving lung cancer care and creating more inclusive clinical trial practices.


Dr. Anna Arthur

Latest:

A Cancer Institution is Seeking to Address Food Insecurity in Patients With Cancer

Dr. Anna Arthur discusses the NOURISH trial, which aims to address food insecurity and malnutrition in patients with blood cancers undergoing treatment.


Dr. Zhaoming Wang

Latest:

Some Pediatric Cancer Treatments Tied to Faster Aging in Survivors

Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.


Shari Mycek

Latest:

Novel 4-Drug Combo Significantly Improves Treatment Responses in Group of Patients with Breast Cancer

Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.


Linda Cohen

Latest:

Can Laughter Help Me Through Cancer?

I've found that making time for a good laugh each day helped break through the looming thought of cancer.


Deborah Harbadin

Latest:

Facing My Mortality from Cancer Made Me Grateful for Loved Ones

Twenty-five years ago, I was diagnosed with ovarian cancer, which sparked fears of leaving my loved ones behind.


Annamarie Kealy

Latest:

My Myeloma Hero Is JP Strong

Initially, we used my husband's diagnosis to show our support as we navigated this journey and joined a new “club” we really didn’t want to be a part of.


Dr. Kandace P. McGuire

Latest:

Targeted Axillary Dissection Offers a Precise Option in Breast Cancer

Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.


Dr. Nausheen Ahmed

Latest:

What Should Patients with Multiple Myeloma Know After ASCO 2025?

Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies following the 2025 ASCO Meeting.


Jacqueline Greer

Latest:

What I Do to Help With Scanxiety

Scans for cancer are never easy, especially when waiting for the results, but I’ve found ways to help me through these intimidating moments.


JoAnn Silcox, M.S.N., RN, CCCTM

Latest:

Conquering Hurdles in Oncology

An oncology nurse strives to educate patients and providers to ensure safe cancer treatment.


Clare Olivares

Latest:

When Cancer Knocks on My Door

When triple-negative breast cancer showed up at my door, I did what I could to prepare for the visit.


Linda Ryan

Latest:

FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.



Dr. Rachit Kumar

Latest:

Raising Awareness on Multidisciplinary Approaches in GI Cancers

Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as per an expert.


William H. Greene, PhD

Latest:

Myeloma Heroes Come in Many Forms

I find myself enormously inadequate to fully explain why I think this lady, my wife, should be selected as a Multiple Myeloma Hero, but whether she is or not, she is my hero.


Dr. Tanja A. Gruber

Latest:

Treatment Advancements Bring Optimism in Infant Leukemia

CURE sat down with Dr. Tanja A. Gruber of Stanford Medicine Children’s Health to discuss clinical trials in infant leukemia.


Cancer Horizons

Latest:

What is Lymphoma

What is Lymphoma - Lymphoma refers to a deadly cancer of your lymphatic system, including the spleen, glands, bone marrow, and lymph nodes (lymph glands).


Dr. Gabriel A. Brooks

Latest:

What Patients With Cancer Should Know About DPD Deficiency Prior to Chemo

Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it.